Viewing data from:

INDOMETHACIN

ANDA

INDOMETHACIN | A201807 | HETERO LABS LTD UNIT III

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.2121

per ea

Lowest NADAC/Unit

$0.2121

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
31722056501INDOMETHACIN ER 75 MG CAPSULE	$0.2121	EA	Generic	—	2026-06-17
31722056560INDOMETHACIN ER 75 MG CAPSULE	$0.2121	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain6 active DMFs6 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

FIS FABBRICA ITALIANA SINTETICI SPAINDOMETHACIN

DMF 31361978

MACLEODS PHARMACEUTICALS LTDINDOMETHACIN

DMF 217402008

CSPC OUYI PHARMACEUTICAL CO LTDINDOMETHACIN

DMF 219842008

HETERO DRUGS LTDINDOMETHACIN

DMF 363642021

AURORE LIFE SCIENCES PRIVATE LTDINDOMETHACIN USP

DMF 367612022

AGNO PHARMAINDOMETHACIN USP

DMF 376382024

INDUSTRIE CHIMICHE FARMACEUTICHE ITALIANE SPAInactiveINDOMETHACIN

DMF 26331976

ESTEVE QUIMICA SAInactiveINDOMETHACIN FOR HUMAN USE

DMF 42201981

SIGMA F AND D DIV LTDInactiveINDOMETHACIN

DMF 52581983

EURAND AMERICA INCInactiveINDOMETHACIN

DMF 59781985

SHANGHAI NO 17 PHARMACEUTICAL FACTORYInactiveINDOMETHACIN

DMF 74941988

GUANGDONG PHARMACEUTICAL FACTORYInactiveINDOMETHACIN

DMF 85811990

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 75MG

0 patents0 exclusivities▴

CAPSULE, EXTENDED RELEASE;ORAL | Approved: Sep 28, 2012

No patent or exclusivity listings for this strength.